Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schroeder

Showing results (451-460 of 481) with videos related to

Pageof 49
Sort By:
Plos One|February 24, 2018
Correction: Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AXJennifer S McDonald, Robert J McDonald, Jacob B Ekins, et al.
Plos One|January 9, 2018
Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AXJennifer S McDonald, Robert J McDonald, Jacob B Ekins, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2011
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenograftsRogier P J Schroeder, W M van Weerden, E P Krenning, et al.
AJPM Focus|October 4, 2023
Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for ImprovementDonna A Santillan, Alexander J Hubb, Taryn E Nishimura, et al.
American Journal of Human Genetics|February 17, 2001
Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancerC H Bock, J M Cunningham, S K McDonnell, et al.
International Journal of Immunogenetics|May 7, 2011
A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysisA F Cristallo, J Schroeder, A Citterio, et al.
Practical Radiation Oncology|April 5, 2026
Implanted Electronic Device Management in a Pencil-Beam Scanning Proton-Therapy ClinicMark D Pepin, Brooke E Ball, Lynette G Stuart-Mullen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 18, 2014
Computed tomographic measures of airway morphology in smokers and never-smoking normalsG R Washko, A A Diaz, V Kim, et al.
American Journal of Human Genetics|March 21, 2000
Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancerR Berry, D J Schaid, J R Smith, et al.
Oncogene|November 21, 1996
Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populationsH Blaszyk, A Hartmann, Y Tamura, et al.
Pageof 49

Showing results (451-460 of 481) with videos related to

Sort By:
Pageof 49
Plos One|February 24, 2018
Correction: Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AXJennifer S McDonald, Robert J McDonald, Jacob B Ekins, et al.
Plos One|January 9, 2018
Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AXJennifer S McDonald, Robert J McDonald, Jacob B Ekins, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 25, 2011
Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenograftsRogier P J Schroeder, W M van Weerden, E P Krenning, et al.
AJPM Focus|October 4, 2023
Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for ImprovementDonna A Santillan, Alexander J Hubb, Taryn E Nishimura, et al.
American Journal of Human Genetics|February 17, 2001
Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancerC H Bock, J M Cunningham, S K McDonnell, et al.
International Journal of Immunogenetics|May 7, 2011
A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysisA F Cristallo, J Schroeder, A Citterio, et al.
Practical Radiation Oncology|April 5, 2026
Implanted Electronic Device Management in a Pencil-Beam Scanning Proton-Therapy ClinicMark D Pepin, Brooke E Ball, Lynette G Stuart-Mullen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 18, 2014
Computed tomographic measures of airway morphology in smokers and never-smoking normalsG R Washko, A A Diaz, V Kim, et al.
American Journal of Human Genetics|March 21, 2000
Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancerR Berry, D J Schaid, J R Smith, et al.
Oncogene|November 21, 1996
Molecular epidemiology of breast cancers in northern and southern Japan: the frequency, clustering, and patterns of p53 gene mutations differ among these two low-risk populationsH Blaszyk, A Hartmann, Y Tamura, et al.
Pageof 49